Cite
APA Citation
Ruhlmann, C., Christensen, T., Dohn, L., Paludan, M., Rannengart, E., Hilpert, F., Feyer, P., Kristensen, G., Keefe, D., Hansen, O., & Herrstedt, J. (n.d.). 34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. European journal of cancer, 51, S727–. http://access.bl.uk/ark:/81055/vdc_100051210954.0x000033